Theravance Biopharma, Inc. (TBPH)

19.66 +0.23 (+1.18%) USD  |  NASDAQ  |  Feb 20, 16:00
19.69 +0.03 (+0.15%) After-Hours: 20:00
More

Theravance Biopharma Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for TBPH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Nektar Therapeutics Upgrade
Innoviva, Inc. Upgrade
Oramed Pharmaceuticals, Inc. Upgrade
Moderna, Inc. Upgrade